/ Not yet recruitingNot Applicable A Randomized, Double-Blind, Active Comparator, Non-Inferiority Study of Subcutaneously Administered Neugranin (Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor) or Pegfilgrastim in Subjects with Breast Cancer Receiving Myelosuppressive Chemotherapy (Doxorubicin/Docetaxel) - NA
100 Clinical Results associated with Teva Pharmaceutical Works Pvt Ltd. Co.
0 Patents (Medical) associated with Teva Pharmaceutical Works Pvt Ltd. Co.
100 Deals associated with Teva Pharmaceutical Works Pvt Ltd. Co.
100 Translational Medicine associated with Teva Pharmaceutical Works Pvt Ltd. Co.